Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer

by Corona, Silvia Paola, Generali, Daniele
Published in Drug Des Devel Ther (2018)

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer

by Ianza, Anna, Sirico, Marianna, Bernocchi, Ottavia, Generali, Daniele
Published in Front Cell Dev Biol (2021)

Breast tumour angiogenesis

by Fox, Stephen B, Generali, Daniele G, Harris, Adrian L
Published 2007

Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma

by Sobhani, Navid, Corona, Silvia P., Zanconati, Fabrizio, Generali, Daniele
Published in Genes Cancer (2017)

Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?

by Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Published in World J Clin Oncol (2018)

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer

by Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Published in World J Clin Oncol (2018)

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer

by Sobhani, Navid, Sirico, Marianna, Generali, Daniele, Zanconati, Fabrizio, Scaggiante, Bruna
Published in World J Clin Oncol (2020)

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

by Sobhani, Navid, Fassl, Anne, Mondani, Giuseppina, Generali, Daniele, Otto, Tobias
Published in Cells (2021)

The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments

by Sobhani, Navid, Fan, Chunmei, O. Flores-Villanueva, Pedro, Generali, Daniele, Li, Yong
Published in Int J Mol Sci (2020)

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

by Cappelletti, Maria Rosa, Gnetti, Letizia, Santini, Daniele, Spada, Daniele, Fox, Stephen B., Generali, Daniele
Published in Oncoscience (2015)

Mutant p53 as an Antigen in Cancer Immunotherapy

by Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Published in Int J Mol Sci (2020)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

by Sobhani, Navid, Tardiel-Cyril, Dana Rae, Davtyan, Aram, Generali, Daniele, Roudi, Raheleh, Li, Yong
Published in Cancers (Basel) (2021)

Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization

by Ganzinelli Monica, Ribeiro Enilze, Bertoni Ramona, Bazzola Letizia, Andreis Daniele, Bottini Alberto, Giardini Roberto, Rossi Camillo, Damia Giovanna, Generali Daniele
Published 2012-04-01

Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization

by Ganzinelli, Monica, Ribeiro, Enilze, Bertoni, Ramona, Bazzola, Letizia, Andreis, Daniele, Bottini, Alberto, Giardini, Roberto, Rossi, Camillo, Damia, Giovanna, Generali, Daniele
Published 2012

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells

by Cretella, Daniele, Fumarola, Claudia, Bonelli, Mara, Alfieri, Roberta, La Monica, Silvia, Digiacomo, Graziana, Cavazzoni, Andrea, Galetti, Maricla, Generali, Daniele, Petronini, Pier Giorgio
Published in Sci Rep (2019)

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition

by Di Modica, Martina, Sfondrini, Lucia, Regondi, Viola, Varchetta, Stefania, Oliviero, Barbara, Mariani, Gabriella, Bianchi, Giulia Valeria, Generali, Daniele, Balsari, Andrea, Triulzi, Tiziana, Tagliabue, Elda
Published in Oncotarget (2015)

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

by Cretella, Daniele, Ravelli, Andrea, Fumarola, Claudia, La Monica, Silvia, Digiacomo, Graziana, Cavazzoni, Andrea, Alfieri, Roberta, Biondi, Alessandra, Generali, Daniele, Bonelli, Mara, Petronini, Pier Giorgio
Published in J Exp Clin Cancer Res (2018)

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes

by Ribeiro, Enilze, Ganzinelli, Monica, Andreis, Daniele, Bertoni, Ramona, Giardini, Roberto, Fox, Stephen B., Broggini, Massimo, Bottini, Alberto, Zanoni, Vanessa, Bazzola, Letizia, Foroni, Chiara, Generali, Daniele, Damia, Giovanna
Published 2013

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

by Triulzi, Tiziana, Regondi, Viola, De Cecco, Loris, Cappelletti, Maria Rosa, Di Modica, Martina, Paolini, Biagio, Lollini, Pier Luigi, Di Cosimo, Serena, Sfondrini, Lucia, Generali, Daniele, Tagliabue, Elda
Published in Br J Cancer (2018)

Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

by Corona, Silvia P., Giudici, Fabiola, Jerusalem, Guy, Ciruelos, Eva, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Dester, Martina, Ziglioli, Nicoletta, Barbieri, Giuseppina, Cervoni, Valeria, Montemurro, Filippo, Generali, Daniele
Published in Oncotarget (2020)